Literature DB >> 20637659

K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling.

Haining Huang1, Myung-Shin Jeon, Lujian Liao, Chun Yang, Chris Elly, John R Yates, Yun-Cai Liu.   

Abstract

Tagging the cell surface receptor with ubiquitin is believed to provide a signal for the endocytic pathway. E3 ubiquitin ligases such as Cbl-b and Itch have been implicated in T cell activation and tolerance induction. However, the underlying mechanisms remain unclear. We describe that in mice deficient in the E3 ubiquitin ligases Cbl-b and Itch, T cell activation was augmented, accompanied by spontaneous autoimmunity. The double-mutant T cells exhibited increased phosphorylation of the T cell receptor-zeta (TCR-zeta) chain, whereas the endocytosis and stability of the TCR complex were not affected. TCR-zeta was polyubiquitinated via a K33-linkage, which affected its phosphorylation and association with the zeta chain-associated protein kinase Zap-70. The juxtamembrane K54 residue in TCR-zeta was identified to be a primary ubiquitin conjugation site, whose mutation increased its phosphorylation and association of TCR-zeta and Zap-70. Thus, the present study reveals unconventional K33-linked polyubiquitination in nonproteolytic regulation of cell-surface-receptor-mediated signal transduction. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637659      PMCID: PMC2927827          DOI: 10.1016/j.immuni.2010.07.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  39 in total

Review 1.  Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins.

Authors:  Linda Hicke; Rebecca Dunn
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

2.  Regulation of constitutive TCR internalization by the zeta-chain.

Authors:  Ugo D'Oro; Ivana Munitic; George Chacko; Tatiana Karpova; James McNally; Jonathan D Ashwell
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

3.  WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation.

Authors:  Alessandra Magnifico; Seth Ettenberg; Cuihong Yang; Jennifer Mariano; Swati Tiwari; Shengyun Fang; Stan Lipkowitz; Allan M Weissman
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

4.  Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.

Authors:  Myung-Shin Jeon; Alex Atfield; K Venuprasad; Connie Krawczyk; Renu Sarao; Chris Elly; Chun Yang; Sudha Arya; Kurt Bachmaier; Leon Su; Dennis Bouchard; Russel Jones; Mathew Gronski; Pamela Ohashi; Teiji Wada; Debra Bloom; C Garrison Fathman; Yun-Cai Liu; Josef M Penninger
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

Review 5.  Ubiquitin ligases and the immune response.

Authors:  Yun-Cai Liu
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

6.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.

Authors:  Vigo Heissmeyer; Fernando Macián; Sin-Hyeog Im; Rajat Varma; Stefan Feske; K Venuprasad; Hua Gu; Yun-Cai Liu; Michael L Dustin; Anjana Rao
Journal:  Nat Immunol       Date:  2004-02-15       Impact factor: 25.606

7.  DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics.

Authors:  David L Tabb; W Hayes McDonald; John R Yates
Journal:  J Proteome Res       Date:  2002 Jan-Feb       Impact factor: 4.466

8.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation.

Authors:  Mayumi Naramura; Ihn-Kyung Jang; Hemanta Kole; Fang Huang; Diana Haines; Hua Gu
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

9.  Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.

Authors:  Philippe Soubeyran; Katarzyna Kowanetz; Iwona Szymkiewicz; Wallace Y Langdon; Ivan Dikic
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

10.  The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.

Authors:  Annalisa Petrelli; Giorgio F Gilestro; Stefania Lanzardo; Paolo M Comoglio; Nicola Migone; Silvia Giordano
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

View more
  72 in total

1.  Segmental isotopic labeling of ubiquitin chains to unravel monomer-specific molecular behavior.

Authors:  Carlos A Castañeda; Liat Spasser; Sudhir N Bavikar; Ashraf Brik; David Fushman
Journal:  Angew Chem Int Ed Engl       Date:  2011-09-28       Impact factor: 15.336

2.  K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.

Authors:  Mingjin Yang; Taoyong Chen; Xuelian Li; Zhou Yu; Songqing Tang; Chen Wang; Yan Gu; Yanfang Liu; Sheng Xu; Weihua Li; Xuemin Zhang; Jianli Wang; Xuetao Cao
Journal:  Nat Immunol       Date:  2015-09-21       Impact factor: 25.606

3.  A data set of human endogenous protein ubiquitination sites.

Authors:  Yi Shi; Doug W Chan; Sung Yun Jung; Anna Malovannaya; Yi Wang; Jun Qin
Journal:  Mol Cell Proteomics       Date:  2010-10-24       Impact factor: 5.911

4.  The E3 ubiquitin ligase Itch is required for the differentiation of follicular helper T cells.

Authors:  Nengming Xiao; Danelle Eto; Chris Elly; Guiying Peng; Shane Crotty; Yun-Cai Liu
Journal:  Nat Immunol       Date:  2014-05-25       Impact factor: 25.606

Review 5.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

Review 6.  Multifaceted role of the ubiquitin ligase Itch in immune regulation.

Authors:  K Venuprasad; Minghui Zeng; Scott L Baughan; Ramin Massoumi
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

Review 7.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

8.  Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.

Authors:  Jonathan D Lee; Jinfang Zhang; Shu-Yu Lin; Yu-Ru Lee; Ming Chen; Tian-Min Fu; Hao Chen; Tomoki Ishikawa; Shang-Yin Chiang; Jesse Katon; Yang Zhang; Yulia V Shulga; Assaf C Bester; Jacqueline Fung; Emanuele Monteleone; Lixin Wan; Chen Shen; Chih-Hung Hsu; Antonella Papa; John G Clohessy; Julie Teruya-Feldstein; Suresh Jain; Hao Wu; Lydia Matesic; Ruey-Hwa Chen; Wenyi Wei; Pier Paolo Pandolfi
Journal:  Science       Date:  2019-05-17       Impact factor: 47.728

9.  Ndfip1 mediates peripheral tolerance to self and exogenous antigen by inducing cell cycle exit in responding CD4+ T cells.

Authors:  John A Altin; Stephen R Daley; Jason Howitt; Helen J Rickards; Alison K Batkin; Keisuke Horikawa; Simon J Prasad; Keats A Nelms; Sharad Kumar; Lawren C Wu; Seong-Seng Tan; Matthew C Cook; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 10.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.